Epigenetic Modification and Differentiation Induction of Malignant Glioma Cells by Oligo-Fucoidan

Mar Drugs. 2019 Sep 8;17(9):525. doi: 10.3390/md17090525.


Malignant glioma (MG) is a poor prognostic brain tumor with inevitable recurrence after multimodality treatment. Searching for more effective treatment is urgently needed. Differentiation induction via epigenetic modification has been proposed as a potential anticancer strategy. Natural products are known as fruitful sources of epigenetic modifiers with wide safety margins. We thus explored the effects of oligo-fucoidan (OF) from brown seaweed on this notion in MG cells including Grade III U87MG cells and Grade IV glioblastoma multiforme (GBM)8401 cells and compared to the immortalized astrocyte SVGp12 cells. The results showed that OF markedly suppress the proliferation of MG cells and only slightly affected that of SVGp12 cells. OF inhibited the protein expressions of DNA methyltransferases 1, 3A and 3B (DNMT1, 3A and 3B) accompanied with obvious mRNA induction of differentiation markers (MBP, OLIG2, S100β, GFAP, NeuN and MAP2) both in U87MG and GBM8401 cells. Accordingly, the methylation of p21, a DNMT3B target gene, was decreased by OF. In combination with the clinical DNMT inhibitor decitabine, OF could synergize the growth inhibition and MBP induction in U87MG cells. Appropriated clinical trials are warranted to evaluate this potential complementary approach for MG therapy after confirmation of the effects in vivo.

Keywords: DNA methyltransferases; differentiation induction; epigenetic modification; malignant glioma; oligo-fucoidan.

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Biomarkers, Tumor / genetics
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / genetics
  • Cell Differentiation / drug effects*
  • Cell Differentiation / genetics
  • Cell Line, Tumor
  • Epigenesis, Genetic / drug effects*
  • Epigenesis, Genetic / genetics
  • Gene Expression Regulation, Neoplastic / drug effects
  • Gene Expression Regulation, Neoplastic / genetics
  • Glioblastoma / drug therapy
  • Glioblastoma / genetics
  • Glioma / drug therapy*
  • Glioma / genetics
  • Humans
  • Neoplasm Recurrence, Local / drug therapy
  • Polysaccharides / pharmacology*


  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Polysaccharides
  • fucoidan